

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.43543709 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.43543709 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.43543709 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.43543709 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.43543709 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.43543709 |
| 7 | negative regulation of phagocytosis (GO:0050765) | 5.59184429 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.15719844 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.15719844 |
| 10 | neutrophil mediated immunity (GO:0002446) | 5.13317022 |
| 11 | response to peptidoglycan (GO:0032494) | 5.08107077 |
| 12 | negative regulation of granulocyte differentiation (GO:0030853) | 4.82171282 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.65432467 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.56479541 |
| 15 | low-density lipoprotein particle clearance (GO:0034383) | 4.47897374 |
| 16 | respiratory burst (GO:0045730) | 4.44161827 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36748008 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 4.36180729 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.35426067 |
| 20 | cellular response to zinc ion (GO:0071294) | 4.34363788 |
| 21 | detection of other organism (GO:0098543) | 4.33091845 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.31636175 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.29596176 |
| 24 | response to host immune response (GO:0052572) | 4.29596176 |
| 25 | B cell receptor signaling pathway (GO:0050853) | 4.24060537 |
| 26 | detection of bacterium (GO:0016045) | 4.22564108 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 4.18174135 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 4.18128494 |
| 29 | negative regulation of mast cell activation (GO:0033004) | 4.17352706 |
| 30 | response to muramyl dipeptide (GO:0032495) | 4.06532480 |
| 31 | microglial cell activation (GO:0001774) | 4.02012428 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.00437590 |
| 33 | regulation of sequestering of triglyceride (GO:0010889) | 3.97017524 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.93931877 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.93872252 |
| 36 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.87884558 |
| 37 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.85812296 |
| 38 | response to host (GO:0075136) | 3.85812296 |
| 39 | response to host defenses (GO:0052200) | 3.85812296 |
| 40 | myeloid leukocyte mediated immunity (GO:0002444) | 3.81771312 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.80853549 |
| 42 | cellular extravasation (GO:0045123) | 3.76155357 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.73232172 |
| 44 | response to protozoan (GO:0001562) | 3.73135616 |
| 45 | positive regulation of heat generation (GO:0031652) | 3.72282692 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.68116903 |
| 47 | superoxide anion generation (GO:0042554) | 3.67097068 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.63103551 |
| 49 | white fat cell differentiation (GO:0050872) | 3.62005139 |
| 50 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.61815825 |
| 51 | cellular response to type I interferon (GO:0071357) | 3.57741324 |
| 52 | type I interferon signaling pathway (GO:0060337) | 3.57741324 |
| 53 | daunorubicin metabolic process (GO:0044597) | 3.55562702 |
| 54 | polyketide metabolic process (GO:0030638) | 3.55562702 |
| 55 | doxorubicin metabolic process (GO:0044598) | 3.55562702 |
| 56 | negative regulation of growth of symbiont in host (GO:0044130) | 3.54219186 |
| 57 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.54219186 |
| 58 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.54219186 |
| 59 | regulation of growth of symbiont in host (GO:0044126) | 3.54219186 |
| 60 | negative regulation of lipid storage (GO:0010888) | 3.53817321 |
| 61 | response to type I interferon (GO:0034340) | 3.53110141 |
| 62 | macrophage activation (GO:0042116) | 3.51690457 |
| 63 | positive regulation of interferon-alpha production (GO:0032727) | 3.51522394 |
| 64 | germinal center formation (GO:0002467) | 3.50818029 |
| 65 | * brown fat cell differentiation (GO:0050873) | 3.49555290 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.47617442 |
| 67 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.47043008 |
| 68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.40543341 |
| 69 | regulation of mast cell activation (GO:0033003) | 3.39981689 |
| 70 | regulation of interferon-alpha production (GO:0032647) | 3.38522915 |
| 71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.37759042 |
| 72 | positive regulation of B cell differentiation (GO:0045579) | 3.37661760 |
| 73 | regulation of cholesterol storage (GO:0010885) | 3.35066221 |
| 74 | neutrophil activation (GO:0042119) | 3.32122687 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.29706103 |
| 76 | T-helper 1 type immune response (GO:0042088) | 3.26867463 |
| 77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26325824 |
| 78 | granulocyte activation (GO:0036230) | 3.21409765 |
| 79 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.20193745 |
| 80 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.20026215 |
| 81 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.19581835 |
| 82 | leukocyte aggregation (GO:0070486) | 3.17499829 |
| 83 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.17450215 |
| 84 | regulation of myeloid cell apoptotic process (GO:0033032) | 3.16653713 |
| 85 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.16616446 |
| 86 | myeloid dendritic cell differentiation (GO:0043011) | 3.16258001 |
| 87 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.15968129 |
| 88 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.15282277 |
| 89 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.12317987 |
| 90 | positive thymic T cell selection (GO:0045059) | 3.11329289 |
| 91 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.10984151 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.10412261 |
| 93 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.08906948 |
| 94 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.08892103 |
| 95 | detection of external biotic stimulus (GO:0098581) | 3.08576108 |
| 96 | detection of biotic stimulus (GO:0009595) | 3.03861093 |
| 97 | regulation of chemokine biosynthetic process (GO:0045073) | 3.03718737 |
| 98 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02156070 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 3.02156070 |
| 100 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.01630135 |
| 101 | positive regulation of type 2 immune response (GO:0002830) | 3.01616693 |
| 102 | regulation of antigen processing and presentation (GO:0002577) | 3.00983727 |
| 103 | leukocyte mediated cytotoxicity (GO:0001909) | 3.00754225 |
| 104 | regulation of B cell differentiation (GO:0045577) | 2.97831998 |
| 105 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.96455035 |
| 106 | lipid storage (GO:0019915) | 2.96092522 |
| 107 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.95926828 |
| 108 | myeloid cell activation involved in immune response (GO:0002275) | 2.95283500 |
| 109 | regulation of leukocyte degranulation (GO:0043300) | 2.92700313 |
| 110 | myeloid dendritic cell activation (GO:0001773) | 2.90374937 |
| 111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.89952491 |
| 112 | * B cell homeostasis (GO:0001782) | 2.89771693 |
| 113 | regulation of granulocyte differentiation (GO:0030852) | 2.89679707 |
| 114 | defense response to protozoan (GO:0042832) | 2.89486345 |
| 115 | positive regulation of mast cell activation (GO:0033005) | 2.88437884 |
| 116 | macrophage differentiation (GO:0030225) | 2.87864078 |
| 117 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.87333407 |
| 118 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.87333407 |
| 119 | I-kappaB phosphorylation (GO:0007252) | 2.87186258 |
| 120 | T cell migration (GO:0072678) | 2.85681749 |
| 121 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85470843 |
| 122 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.84202342 |
| 123 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.83523160 |
| 124 | reactive oxygen species biosynthetic process (GO:1903409) | 2.83019621 |
| 125 | B cell mediated immunity (GO:0019724) | 2.81097243 |
| 126 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.80081736 |
| 127 | regulation of fever generation (GO:0031620) | 2.79957985 |
| 128 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.79766331 |
| 129 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.79610159 |
| 130 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79043498 |
| 131 | histamine secretion (GO:0001821) | 2.78803149 |
| 132 | positive regulation of chemokine production (GO:0032722) | 2.78616087 |
| 133 | modulation by symbiont of host cellular process (GO:0044068) | 2.78597729 |
| 134 | negative regulation of interleukin-6 production (GO:0032715) | 2.77758893 |
| 135 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72925575 |
| 136 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.71421766 |
| 137 | NIK/NF-kappaB signaling (GO:0038061) | 2.70718310 |
| 138 | regulation of lipid storage (GO:0010883) | 2.70324371 |
| 139 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.70198845 |
| 140 | response to interleukin-15 (GO:0070672) | 2.69130128 |
| 141 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.69070678 |
| 142 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.68307428 |
| 143 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.68307428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.71122370 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.72975665 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.01148587 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.35000813 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.09543484 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.05526450 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.96479912 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.91406012 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.85010416 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.65650384 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.60726518 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41806020 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.18144262 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.12896223 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.04740873 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.93526470 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.83336262 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77066287 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69908151 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.69289652 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.64359576 |
| 22 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.55173293 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.47953302 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.41582931 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29592781 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28463756 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.12916818 |
| 28 | * MYC_22102868_ChIP-Seq_BL_Human | 2.06656763 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.03613755 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 2.02546646 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00462775 |
| 32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.99702000 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99345717 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91901128 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90198206 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.89004337 |
| 37 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.84935583 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81828496 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81329904 |
| 40 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.79604786 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77703992 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76150826 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63054829 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62715654 |
| 45 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62591726 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61761015 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.61727884 |
| 48 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.55733608 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55506938 |
| 50 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55310928 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54108053 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53945455 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.52713147 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52156738 |
| 55 | P68_20966046_ChIP-Seq_HELA_Human | 1.52092429 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.50537722 |
| 57 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.48398230 |
| 58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47876311 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47484829 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.46769332 |
| 61 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46654502 |
| 62 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45612962 |
| 63 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.44565620 |
| 64 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.43792614 |
| 65 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.39635796 |
| 66 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.38882950 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.37128265 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.32544932 |
| 69 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32475598 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32229493 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32129497 |
| 72 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.29526760 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29247075 |
| 74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.27937567 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27612381 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27450622 |
| 77 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27100379 |
| 78 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.25354889 |
| 79 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23739138 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 1.22856079 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22185318 |
| 82 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21726208 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20937063 |
| 84 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.20413960 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19875553 |
| 86 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.19418231 |
| 87 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18088303 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.17255338 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17120067 |
| 90 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15329824 |
| 91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12397746 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11664953 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11567731 |
| 94 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09646375 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06832140 |
| 96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06639293 |
| 97 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06232974 |
| 98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06093450 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06059720 |
| 100 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04370539 |
| 101 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04286315 |
| 102 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03735255 |
| 103 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03157351 |
| 104 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01671074 |
| 105 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.01643875 |
| 106 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00378700 |
| 107 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98720450 |
| 108 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96903172 |
| 109 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96183265 |
| 110 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96151300 |
| 111 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.95285227 |
| 112 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92764546 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 0.92324192 |
| 114 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90926872 |
| 115 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.90466429 |
| 116 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86067186 |
| 117 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85040863 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82863263 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82370402 |
| 120 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82103172 |
| 121 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78860947 |
| 122 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78631501 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78143042 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78126301 |
| 125 | GATA3_26560356_Chip-Seq_TH2_Human | 0.76847588 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75752307 |
| 127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73667331 |
| 128 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70815869 |
| 129 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69843315 |
| 130 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.68042397 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63904669 |
| 132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.63119027 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.62217784 |
| 134 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.60181883 |
| 135 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.59614282 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.57578612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 3.80301781 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.65718425 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.57132803 |
| 4 | MP0005451_abnormal_body_composition | 3.56018379 |
| 5 | MP0003303_peritoneal_inflammation | 3.16955548 |
| 6 | MP0003436_decreased_susceptibility_to | 3.05232615 |
| 7 | MP0002419_abnormal_innate_immunity | 2.94889425 |
| 8 | MP0003724_increased_susceptibility_to | 2.87653898 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.68785544 |
| 10 | MP0009785_altered_susceptibility_to | 2.66347920 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.39120691 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.37737079 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.36235516 |
| 14 | MP0005025_abnormal_response_to | 2.34084401 |
| 15 | MP0005387_immune_system_phenotype | 2.26727047 |
| 16 | MP0001790_abnormal_immune_system | 2.26727047 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.23591237 |
| 18 | * MP0001800_abnormal_humoral_immune | 2.21693652 |
| 19 | MP0005666_abnormal_adipose_tissue | 2.18794583 |
| 20 | MP0009278_abnormal_bone_marrow | 2.16928376 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.13631345 |
| 22 | MP0000015_abnormal_ear_pigmentation | 2.12480136 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.08671356 |
| 24 | * MP0002723_abnormal_immune_serum | 2.02506067 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.01829272 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 2.01255506 |
| 27 | * MP0001819_abnormal_immune_cell | 2.00790008 |
| 28 | MP0004185_abnormal_adipocyte_glucose | 2.00024055 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.96013603 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.96013603 |
| 31 | MP0000343_altered_response_to | 1.88915896 |
| 32 | MP0004510_myositis | 1.87317341 |
| 33 | MP0008260_abnormal_autophagy | 1.84809903 |
| 34 | MP0004130_abnormal_muscle_cell | 1.83532980 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.78213339 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.76935145 |
| 37 | MP0005671_abnormal_response_to | 1.72426199 |
| 38 | MP0002971_abnormal_brown_adipose | 1.63314266 |
| 39 | MP0000685_abnormal_immune_system | 1.62788287 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.59882815 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.51646461 |
| 42 | MP0008438_abnormal_cutaneous_collagen | 1.50392503 |
| 43 | MP0005310_abnormal_salivary_gland | 1.49741765 |
| 44 | MP0005375_adipose_tissue_phenotype | 1.49022751 |
| 45 | MP0009115_abnormal_fat_cell | 1.48263847 |
| 46 | MP0003448_altered_tumor_morphology | 1.45840918 |
| 47 | MP0002405_respiratory_system_inflammati | 1.44785556 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.44753549 |
| 49 | * MP0000716_abnormal_immune_system | 1.43882861 |
| 50 | * MP0002398_abnormal_bone_marrow | 1.43266960 |
| 51 | MP0004381_abnormal_hair_follicle | 1.39533203 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.36793107 |
| 53 | MP0001853_heart_inflammation | 1.36582122 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.36379884 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.34808931 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.33771611 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.30845461 |
| 58 | MP0006082_CNS_inflammation | 1.27417200 |
| 59 | MP0000750_abnormal_muscle_regeneration | 1.27258618 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.27190672 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.26292015 |
| 62 | * MP0002429_abnormal_blood_cell | 1.19630648 |
| 63 | MP0000371_diluted_coat_color | 1.19592379 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.18852875 |
| 65 | MP0003075_altered_response_to | 1.18745491 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.17826908 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.15048758 |
| 68 | MP0003828_pulmonary_edema | 1.14555794 |
| 69 | MP0004858_abnormal_nervous_system | 1.14412193 |
| 70 | MP0005334_abnormal_fat_pad | 1.14085062 |
| 71 | MP0002132_abnormal_respiratory_system | 1.14055712 |
| 72 | MP0009840_abnormal_foam_cell | 1.13392596 |
| 73 | MP0008469_abnormal_protein_level | 1.11753443 |
| 74 | MP0000747_muscle_weakness | 1.10317955 |
| 75 | MP0001873_stomach_inflammation | 1.09587298 |
| 76 | MP0009764_decreased_sensitivity_to | 1.08446267 |
| 77 | MP0002970_abnormal_white_adipose | 1.07786114 |
| 78 | MP0000858_altered_metastatic_potential | 1.07248438 |
| 79 | MP0003866_abnormal_defecation | 1.05979744 |
| 80 | MP0002166_altered_tumor_susceptibility | 1.03762905 |
| 81 | MP0002722_abnormal_immune_system | 1.03127885 |
| 82 | MP0001851_eye_inflammation | 1.03034583 |
| 83 | MP0001663_abnormal_digestive_system | 1.02669916 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.02355926 |
| 85 | MP0000490_abnormal_crypts_of | 1.01966717 |
| 86 | MP0002933_joint_inflammation | 1.00780988 |
| 87 | MP0005164_abnormal_response_to | 1.00672741 |
| 88 | MP0005166_decreased_susceptibility_to | 1.00573020 |
| 89 | MP0005390_skeleton_phenotype | 1.00176388 |
| 90 | MP0002006_tumorigenesis | 0.99478049 |
| 91 | MP0009333_abnormal_splenocyte_physiolog | 0.99422616 |
| 92 | MP0003646_muscle_fatigue | 0.97906086 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.97713769 |
| 94 | MP0010307_abnormal_tumor_latency | 0.94198644 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 0.92603777 |
| 96 | MP0004233_abnormal_muscle_weight | 0.91386512 |
| 97 | MP0000249_abnormal_blood_vessel | 0.91071757 |
| 98 | MP0000759_abnormal_skeletal_muscle | 0.90509028 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.88262331 |
| 100 | MP0003300_gastrointestinal_ulcer | 0.87385953 |
| 101 | MP0004883_abnormal_blood_vessel | 0.86051708 |
| 102 | MP0003705_abnormal_hypodermis_morpholog | 0.85119698 |
| 103 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84644837 |
| 104 | MP0008874_decreased_physiological_sensi | 0.84481117 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.84374407 |
| 106 | MP0001879_abnormal_lymphatic_vessel | 0.83928725 |
| 107 | MP0002095_abnormal_skin_pigmentation | 0.83043559 |
| 108 | MP0008004_abnormal_stomach_pH | 0.81511186 |
| 109 | MP0003690_abnormal_glial_cell | 0.80332513 |
| 110 | MP0002106_abnormal_muscle_physiology | 0.79291909 |
| 111 | MP0000003_abnormal_adipose_tissue | 0.75352186 |
| 112 | MP0001849_ear_inflammation | 0.75047062 |
| 113 | MP0005535_abnormal_body_temperature | 0.74051243 |
| 114 | MP0002254_reproductive_system_inflammat | 0.73748740 |
| 115 | MP0005448_abnormal_energy_balance | 0.72088860 |
| 116 | MP0000749_muscle_degeneration | 0.70728479 |
| 117 | MP0009763_increased_sensitivity_to | 0.70298116 |
| 118 | MP0003091_abnormal_cell_migration | 0.70237865 |
| 119 | MP0002928_abnormal_bile_duct | 0.68620756 |
| 120 | MP0000678_abnormal_parathyroid_gland | 0.68162724 |
| 121 | MP0008961_abnormal_basal_metabolism | 0.66901224 |
| 122 | MP0005381_digestive/alimentary_phenotyp | 0.66533467 |
| 123 | MP0002075_abnormal_coat/hair_pigmentati | 0.66466779 |
| 124 | MP0009697_abnormal_copulation | 0.66365945 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.65508741 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.65298336 |
| 127 | MP0006292_abnormal_olfactory_placode | 0.65106756 |
| 128 | MP0004947_skin_inflammation | 0.64326879 |
| 129 | MP0003186_abnormal_redox_activity | 0.63380053 |
| 130 | MP0004087_abnormal_muscle_fiber | 0.63270802 |
| 131 | MP0003879_abnormal_hair_cell | 0.60931362 |
| 132 | MP0000604_amyloidosis | 0.60917200 |
| 133 | MP0001175_abnormal_lung_morphology | 0.60201683 |
| 134 | MP0003045_fibrosis | 0.59955414 |
| 135 | MP0002938_white_spotting | 0.59401251 |
| 136 | MP0000733_abnormal_muscle_development | 0.58545598 |
| 137 | MP0004036_abnormal_muscle_relaxation | 0.58332927 |
| 138 | MP0000751_myopathy | 0.58066148 |
| 139 | MP0002653_abnormal_ependyma_morphology | 0.57335022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.30936209 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.63775699 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.33658520 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.95151134 |
| 5 | Myositis (HP:0100614) | 4.28336872 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.24960619 |
| 7 | Gastrointestinal stroma tumor (HP:0100723) | 4.12111864 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 4.03141090 |
| 9 | Obstructive lung disease (HP:0006536) | 4.03141090 |
| 10 | Orchitis (HP:0100796) | 3.94424225 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.90885912 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.80124302 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.49894728 |
| 14 | Optic neuritis (HP:0100653) | 3.49894728 |
| 15 | Exercise-induced myalgia (HP:0003738) | 3.49299979 |
| 16 | Increased IgE level (HP:0003212) | 3.38208925 |
| 17 | Muscle fiber inclusion bodies (HP:0100299) | 3.36874619 |
| 18 | Hematochezia (HP:0002573) | 3.36248780 |
| 19 | Recurrent skin infections (HP:0001581) | 3.32541881 |
| 20 | Nemaline bodies (HP:0003798) | 3.22163051 |
| 21 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.17591642 |
| 22 | Cellulitis (HP:0100658) | 3.15946136 |
| 23 | Vasculitis (HP:0002633) | 3.15496288 |
| 24 | Lymphopenia (HP:0001888) | 3.11195417 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.06945025 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.05510750 |
| 27 | Gingivitis (HP:0000230) | 3.03867008 |
| 28 | Chronic otitis media (HP:0000389) | 3.03418381 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.03190855 |
| 30 | Meningitis (HP:0001287) | 2.99280962 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 2.95149819 |
| 32 | Encephalitis (HP:0002383) | 2.94401569 |
| 33 | Myopathic facies (HP:0002058) | 2.91156687 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.86945090 |
| 35 | Recurrent sinusitis (HP:0011108) | 2.85922108 |
| 36 | Stomatitis (HP:0010280) | 2.81407138 |
| 37 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.76937924 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.75636299 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.75636299 |
| 40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.75636299 |
| 41 | Colitis (HP:0002583) | 2.68199998 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.65975161 |
| 43 | Thrombocytosis (HP:0001894) | 2.65543749 |
| 44 | Recurrent lower respiratory tract infections (HP:0002783) | 2.65128643 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.61713770 |
| 46 | Recurrent viral infections (HP:0004429) | 2.61637058 |
| 47 | Oligomenorrhea (HP:0000876) | 2.61530051 |
| 48 | Recurrent pneumonia (HP:0006532) | 2.60315883 |
| 49 | Difficulty running (HP:0009046) | 2.59125916 |
| 50 | Emphysema (HP:0002097) | 2.58934972 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.57614739 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.57614739 |
| 53 | IgM deficiency (HP:0002850) | 2.57337998 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.56761058 |
| 55 | Osteomyelitis (HP:0002754) | 2.56212527 |
| 56 | Abnormality of the prostate (HP:0008775) | 2.53198948 |
| 57 | Urticaria (HP:0001025) | 2.51333311 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.49029523 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.48950099 |
| 60 | Prostate neoplasm (HP:0100787) | 2.47835470 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.47735955 |
| 62 | Cutaneous melanoma (HP:0012056) | 2.46961921 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.43357270 |
| 64 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.42844898 |
| 65 | Increased connective tissue (HP:0009025) | 2.38199390 |
| 66 | Hypochromic anemia (HP:0001931) | 2.36752920 |
| 67 | Hypertensive crisis (HP:0100735) | 2.36025095 |
| 68 | Increased IgM level (HP:0003496) | 2.35768794 |
| 69 | Panhypogammaglobulinemia (HP:0003139) | 2.34644109 |
| 70 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.34476235 |
| 71 | Type 1 muscle fiber predominance (HP:0003803) | 2.33180219 |
| 72 | Spinal cord lesions (HP:0100561) | 2.33003113 |
| 73 | Syringomyelia (HP:0003396) | 2.33003113 |
| 74 | Tetraparesis (HP:0002273) | 2.31490200 |
| 75 | Leukocytosis (HP:0001974) | 2.31021958 |
| 76 | Hemoptysis (HP:0002105) | 2.29717707 |
| 77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.29230107 |
| 78 | Albinism (HP:0001022) | 2.27998733 |
| 79 | Premature loss of primary teeth (HP:0006323) | 2.27922703 |
| 80 | Purpura (HP:0000979) | 2.24994607 |
| 81 | Bulbar palsy (HP:0001283) | 2.24964705 |
| 82 | Disinhibition (HP:0000734) | 2.23954610 |
| 83 | Papilloma (HP:0012740) | 2.23301537 |
| 84 | Verrucae (HP:0200043) | 2.23301537 |
| 85 | Periodontitis (HP:0000704) | 2.21817723 |
| 86 | Glomerulopathy (HP:0100820) | 2.20356773 |
| 87 | Increased variability in muscle fiber diameter (HP:0003557) | 2.20118491 |
| 88 | Abnormality of the pleura (HP:0002103) | 2.19942430 |
| 89 | J-shaped sella turcica (HP:0002680) | 2.19448236 |
| 90 | EMG: myopathic abnormalities (HP:0003458) | 2.19382123 |
| 91 | Abnormality of the lumbar spine (HP:0100712) | 2.18092382 |
| 92 | Hypertriglyceridemia (HP:0002155) | 2.15946584 |
| 93 | Ulnar deviation of the wrist (HP:0003049) | 2.14508521 |
| 94 | Episodic fever (HP:0001954) | 2.13287605 |
| 95 | Keratoconjunctivitis sicca (HP:0001097) | 2.12247694 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11997118 |
| 97 | Muscle fiber splitting (HP:0003555) | 2.11120600 |
| 98 | Recurrent bronchitis (HP:0002837) | 2.10796353 |
| 99 | Myocardial infarction (HP:0001658) | 2.08595886 |
| 100 | Bone pain (HP:0002653) | 2.08464955 |
| 101 | Increased serum ferritin (HP:0003281) | 2.07445349 |
| 102 | Ragged-red muscle fibers (HP:0003200) | 2.05988186 |
| 103 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05907065 |
| 104 | Amyloidosis (HP:0011034) | 2.05294288 |
| 105 | Agammaglobulinemia (HP:0004432) | 2.01386775 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 2.01119643 |
| 107 | Gingival bleeding (HP:0000225) | 2.00555772 |
| 108 | Nausea (HP:0002018) | 1.99562670 |
| 109 | Abnormality of the peritoneum (HP:0002585) | 1.99426097 |
| 110 | Viral hepatitis (HP:0006562) | 1.98444843 |
| 111 | Bone cyst (HP:0012062) | 1.98393907 |
| 112 | Arterial thrombosis (HP:0004420) | 1.97893538 |
| 113 | Easy fatigability (HP:0003388) | 1.97335146 |
| 114 | Restrictive lung disease (HP:0002091) | 1.96566351 |
| 115 | Thoracic kyphosis (HP:0002942) | 1.95130023 |
| 116 | Acrocyanosis (HP:0001063) | 1.95024362 |
| 117 | Abnormality of T cell physiology (HP:0011840) | 1.93652252 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 1.93557667 |
| 119 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93355107 |
| 120 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92804745 |
| 121 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92804745 |
| 122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92804745 |
| 123 | Abnormality of the endocardium (HP:0004306) | 1.92160149 |
| 124 | Distal lower limb muscle weakness (HP:0009053) | 1.92039819 |
| 125 | Rhabdomyolysis (HP:0003201) | 1.91936211 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.91515706 |
| 127 | Distal arthrogryposis (HP:0005684) | 1.91007696 |
| 128 | Hyporeflexia of lower limbs (HP:0002600) | 1.89993453 |
| 129 | Abnormality of the fingertips (HP:0001211) | 1.89635281 |
| 130 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88952432 |
| 131 | Chest pain (HP:0100749) | 1.88153901 |
| 132 | Agnosia (HP:0010524) | 1.87950679 |
| 133 | Deformed sella turcica (HP:0002681) | 1.87695840 |
| 134 | Exercise-induced muscle cramps (HP:0003710) | 1.87337673 |
| 135 | Keratoconjunctivitis (HP:0001096) | 1.86312565 |
| 136 | Cheilitis (HP:0100825) | 1.86271246 |
| 137 | Sepsis (HP:0100806) | 1.85055367 |
| 138 | Petechiae (HP:0000967) | 1.85043937 |
| 139 | Neoplasm of the adrenal cortex (HP:0100641) | 1.85024235 |
| 140 | Anorexia (HP:0002039) | 1.84412526 |
| 141 | Dysostosis multiplex (HP:0000943) | 1.84165260 |
| 142 | Loss of speech (HP:0002371) | 1.83879559 |
| 143 | Chronic sinusitis (HP:0011109) | 1.83812013 |
| 144 | Hydroxyprolinuria (HP:0003080) | 1.82507268 |
| 145 | Abnormality of proline metabolism (HP:0010907) | 1.82507268 |
| 146 | Eosinophilia (HP:0001880) | 1.82469230 |
| 147 | Periorbital edema (HP:0100539) | 1.80512126 |
| 148 | Glomerulonephritis (HP:0000099) | 1.79291639 |
| 149 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79287964 |
| 150 | Mucopolysacchariduria (HP:0008155) | 1.79287964 |
| 151 | Axonal loss (HP:0003447) | 1.78371741 |
| 152 | Facial edema (HP:0000282) | 1.77804469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 3.82182844 |
| 2 | IRAK3 | 3.43404841 |
| 3 | CAMK1D | 3.30884625 |
| 4 | MAP3K14 | 3.27467743 |
| 5 | BLK | 3.21745532 |
| 6 | SIK3 | 3.18340124 |
| 7 | MAP4K1 | 3.09394879 |
| 8 | TBK1 | 2.58068657 |
| 9 | SMG1 | 2.47235379 |
| 10 | CAMK1G | 2.29004215 |
| 11 | KIT | 2.26957389 |
| 12 | TGFBR2 | 2.25614773 |
| 13 | ERN1 | 2.15130599 |
| 14 | CSF1R | 2.14376063 |
| 15 | TYK2 | 2.13848924 |
| 16 | SIK2 | 2.09793620 |
| 17 | TAOK2 | 2.04990851 |
| 18 | TNK2 | 1.87694001 |
| 19 | MAP3K13 | 1.71585284 |
| 20 | PIM2 | 1.69477822 |
| 21 | SIK1 | 1.63232482 |
| 22 | RIPK4 | 1.60642722 |
| 23 | TEC | 1.56347693 |
| 24 | TXK | 1.54528701 |
| 25 | IKBKB | 1.52290641 |
| 26 | SYK | 1.45632228 |
| 27 | EIF2AK2 | 1.44618594 |
| 28 | GRK6 | 1.43455776 |
| 29 | FES | 1.42711034 |
| 30 | RPS6KA4 | 1.38824395 |
| 31 | TRIB3 | 1.38302544 |
| 32 | JAK3 | 1.38255377 |
| 33 | IKBKE | 1.35778068 |
| 34 | NME2 | 1.35081959 |
| 35 | MARK2 | 1.34909922 |
| 36 | TTN | 1.34753279 |
| 37 | ICK | 1.29066112 |
| 38 | BTK | 1.28522699 |
| 39 | OBSCN | 1.27104891 |
| 40 | MAP3K1 | 1.20521479 |
| 41 | MAP2K3 | 1.19979814 |
| 42 | HCK | 1.19485970 |
| 43 | LYN | 1.18702539 |
| 44 | IRAK2 | 1.14988185 |
| 45 | ZAP70 | 1.13177269 |
| 46 | JAK1 | 1.11626150 |
| 47 | TIE1 | 1.11152337 |
| 48 | VRK1 | 1.06531770 |
| 49 | CSK | 1.05760738 |
| 50 | CLK1 | 1.02710897 |
| 51 | BRD4 | 1.01783682 |
| 52 | PIM1 | 0.99776819 |
| 53 | CDC42BPA | 0.99555804 |
| 54 | ABL2 | 0.99555651 |
| 55 | PAK4 | 0.98602440 |
| 56 | PRKD2 | 0.98369802 |
| 57 | TAOK3 | 0.97253869 |
| 58 | MARK3 | 0.95579300 |
| 59 | CAMKK2 | 0.93004465 |
| 60 | TESK2 | 0.90387534 |
| 61 | CHUK | 0.90071650 |
| 62 | YES1 | 0.89149132 |
| 63 | CDK19 | 0.86468398 |
| 64 | KSR2 | 0.86178630 |
| 65 | ERBB3 | 0.85192117 |
| 66 | RPS6KA6 | 0.83647888 |
| 67 | MAP3K6 | 0.81061003 |
| 68 | RPS6KC1 | 0.79434509 |
| 69 | RPS6KL1 | 0.79434509 |
| 70 | DYRK1B | 0.79333340 |
| 71 | PDPK1 | 0.78904770 |
| 72 | MAP3K10 | 0.76871729 |
| 73 | LRRK2 | 0.76844058 |
| 74 | IRAK1 | 0.76376081 |
| 75 | CAMK4 | 0.76134518 |
| 76 | PDK1 | 0.75469881 |
| 77 | MAPK4 | 0.74409491 |
| 78 | CDK9 | 0.74256166 |
| 79 | DAPK2 | 0.72909418 |
| 80 | MAP2K4 | 0.67612503 |
| 81 | LCK | 0.66201511 |
| 82 | FLT3 | 0.65033594 |
| 83 | MAP3K7 | 0.63504184 |
| 84 | PRPF4B | 0.62626387 |
| 85 | ARAF | 0.61934439 |
| 86 | BRAF | 0.61368879 |
| 87 | FGFR4 | 0.58713480 |
| 88 | MAPK11 | 0.57787935 |
| 89 | RIPK1 | 0.57728743 |
| 90 | RPS6KA2 | 0.57627072 |
| 91 | JAK2 | 0.53726076 |
| 92 | MAP3K8 | 0.53629540 |
| 93 | MKNK2 | 0.53509474 |
| 94 | MOS | 0.52947882 |
| 95 | ABL1 | 0.52578931 |
| 96 | CDK12 | 0.52188998 |
| 97 | NUAK1 | 0.51598312 |
| 98 | GRK7 | 0.51268481 |
| 99 | ATR | 0.51017990 |
| 100 | CDK4 | 0.50507667 |
| 101 | STK11 | 0.50157069 |
| 102 | BCKDK | 0.49864406 |
| 103 | MAPK7 | 0.48615839 |
| 104 | PRKAA2 | 0.48289777 |
| 105 | DYRK2 | 0.48055428 |
| 106 | MATK | 0.47530704 |
| 107 | SGK3 | 0.47188652 |
| 108 | MARK1 | 0.46870515 |
| 109 | PRKCQ | 0.46695777 |
| 110 | PTK6 | 0.46082081 |
| 111 | HIPK2 | 0.44865041 |
| 112 | FGFR3 | 0.43337478 |
| 113 | PRKCD | 0.42523895 |
| 114 | ALK | 0.42134233 |
| 115 | PIK3CG | 0.40621438 |
| 116 | STK10 | 0.38499530 |
| 117 | MAP2K2 | 0.37384332 |
| 118 | MAPK15 | 0.36794734 |
| 119 | EPHA3 | 0.36368503 |
| 120 | EPHB1 | 0.36135296 |
| 121 | CDK8 | 0.35922756 |
| 122 | DYRK3 | 0.35813381 |
| 123 | FYN | 0.35739724 |
| 124 | ITK | 0.35377958 |
| 125 | PRKG2 | 0.34084062 |
| 126 | MUSK | 0.33995801 |
| 127 | EEF2K | 0.33278961 |
| 128 | MAP3K11 | 0.33117526 |
| 129 | PRKCZ | 0.33014129 |
| 130 | MAPKAPK2 | 0.31669063 |
| 131 | MAP3K3 | 0.31668736 |
| 132 | TRPM7 | 0.31628034 |
| 133 | MAPK12 | 0.31619553 |
| 134 | RPS6KB1 | 0.31095798 |
| 135 | BMX | 0.30599374 |
| 136 | CAMK1 | 0.30569313 |
| 137 | CAMKK1 | 0.30368309 |
| 138 | PKN2 | 0.30016156 |
| 139 | MAPK3 | 0.28788613 |
| 140 | TAOK1 | 0.28151356 |
| 141 | FGR | 0.28078802 |
| 142 | KDR | 0.27202673 |
| 143 | MAPK13 | 0.26766794 |
| 144 | CDK6 | 0.25977537 |
| 145 | RPS6KA1 | 0.23959002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.19808405 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.73726733 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.57915723 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43841258 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43718531 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.35419395 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.33131556 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.09240347 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.01907570 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.00288318 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.97000342 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.91792799 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.91323687 |
| 14 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.83534474 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.80518284 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.74855113 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71053640 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.70037631 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64930535 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60224932 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54806395 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54693516 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.54557927 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.53057099 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.52569197 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.47595539 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.45829216 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44636472 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43427387 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41447857 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.39504651 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38128014 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.37617386 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34616875 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32378491 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.32302391 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.30129541 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26584398 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25159259 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.22166142 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18971914 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16127090 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14180613 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13938618 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.13423208 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 1.13386278 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12648412 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.10220000 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05747089 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.05344340 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05138721 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05074985 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03990215 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03216234 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01209144 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00230210 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.98542636 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97968823 |
| 59 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91462021 |
| 60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.91441705 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89944597 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88254111 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87823123 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85936585 |
| 65 | Allograft rejection_Homo sapiens_hsa05330 | 0.84737421 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.80465241 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79795959 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76357034 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75877169 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.75014526 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.74816688 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73648264 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73354351 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72475860 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68311030 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67744699 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66480294 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65387175 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63438976 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62853668 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61400488 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61352562 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61230697 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61209155 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60603191 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59789283 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.59389933 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58695432 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58185773 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57058496 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.57055920 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55563661 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55182548 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55064736 |
| 95 | Mismatch repair_Homo sapiens_hsa03430 | 0.54777940 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52930983 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52462157 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.52315649 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.51314410 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48169526 |
| 101 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48123986 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47075932 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45896319 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45773513 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45402465 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45389796 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44473345 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.43886317 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42473372 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42230957 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42166368 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40666085 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38016920 |
| 114 | Olfactory transduction_Homo sapiens_hsa04740 | 0.36875286 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35602022 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35513409 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.34921476 |
| 118 | Melanoma_Homo sapiens_hsa05218 | 0.34512141 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33304996 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32699701 |
| 121 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32663592 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32413234 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32019923 |

